Multi-target drugs: the trend of drug research and development
Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to...
Gespeichert in:
Veröffentlicht in: | PloS one 2012-06, Vol.7 (6), p.e40262-e40262 |
---|---|
Hauptverfasser: | , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | e40262 |
---|---|
container_issue | 6 |
container_start_page | e40262 |
container_title | PloS one |
container_volume | 7 |
creator | Lu, Jin-Jian Pan, Wei Hu, Yuan-Jia Wang, Yi-Tao |
description | Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future. |
doi_str_mv | 10.1371/journal.pone.0040262 |
format | Article |
fullrecord | <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1325045108</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A477004374</galeid><doaj_id>oai_doaj_org_article_f6283dfec24b479691143ee4b62ab1cc</doaj_id><sourcerecordid>A477004374</sourcerecordid><originalsourceid>FETCH-LOGICAL-c692t-808a70f795eb58b3de488943a6d0133f08c885a9c467c86a74bd69815a06a7253</originalsourceid><addsrcrecordid>eNqNkltrFDEUxwdRbK1-A9EBQfRh19wmFx8KpXhZqBS8vYZM5szslOxkTTJFv73Z7rTsSB8kD0lOfuefnJN_UTzHaImpwO-u_BgG45ZbP8ASIYYIJw-KY6woWXCC6MOD9VHxJMYrhCoqOX9cHBEiuCScHxenX0aX-kUyoYNUNmHs4vsyraFMAYam9O1NrAwQwQS7Lk0ONnANzm83MKSnxaPWuAjPpvmk-PHxw_fzz4uLy0-r87OLheWKpIVE0gjUClVBXcmaNsCkVIwa3iBMaYuklbIyyjIurORGsLrhSuLKoLwhFT0pXu51t85HPZUeNaakQqzCSGZitScab670NvQbE_5ob3p9E_Ch0yak3jrQLSeSNi1YwmomFFcYMwrAak5Mja3NWqfTbWO9gcbmQoNxM9H5ydCvdeevNc39VUJlgTeTQPC_RohJb_powTkzgB_zuxFhSAle0Yy--ge9v7qJ6kwuoB9an--1O1F9xoTI308Fy9TyHiqPBja9zT5p-xyfJbydJWQmwe_UmTFGvfr29f_Zy59z9vUBuwbj0jp6N6beD3EOsj1og48xQHvXZIz0zua33dA7m-vJ5jntxeEH3SXd-pr-BZZz9Tg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1325045108</pqid></control><display><type>article</type><title>Multi-target drugs: the trend of drug research and development</title><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Public Library of Science (PLoS)</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>Free Full-Text Journals in Chemistry</source><creator>Lu, Jin-Jian ; Pan, Wei ; Hu, Yuan-Jia ; Wang, Yi-Tao</creator><contributor>Aggarwal, Bharat B.</contributor><creatorcontrib>Lu, Jin-Jian ; Pan, Wei ; Hu, Yuan-Jia ; Wang, Yi-Tao ; Aggarwal, Bharat B.</creatorcontrib><description>Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0040262</identifier><identifier>PMID: 22768266</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Alzheimer's disease ; Angiogenesis ; Cancer therapies ; Dopamine ; Drug approval ; Drug development ; Drug discovery ; Drug Discovery - economics ; Drug Discovery - trends ; Drugs ; Functional foods & nutraceuticals ; Growth factors ; Industrial research ; Kinases ; Laboratories ; Marketing - economics ; Medicine ; Metastasis ; Natural products ; Nervous system ; Network analysis ; Parkinson's disease ; Pharmaceutical Preparations - economics ; R&D ; Research & development ; Research - economics ; Research - trends ; Studies</subject><ispartof>PloS one, 2012-06, Vol.7 (6), p.e40262-e40262</ispartof><rights>COPYRIGHT 2012 Public Library of Science</rights><rights>2012 Lu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Lu et al. 2012</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c692t-808a70f795eb58b3de488943a6d0133f08c885a9c467c86a74bd69815a06a7253</citedby><cites>FETCH-LOGICAL-c692t-808a70f795eb58b3de488943a6d0133f08c885a9c467c86a74bd69815a06a7253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386979/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386979/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,2102,2928,23866,27924,27925,53791,53793,79600,79601</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/22768266$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><contributor>Aggarwal, Bharat B.</contributor><creatorcontrib>Lu, Jin-Jian</creatorcontrib><creatorcontrib>Pan, Wei</creatorcontrib><creatorcontrib>Hu, Yuan-Jia</creatorcontrib><creatorcontrib>Wang, Yi-Tao</creatorcontrib><title>Multi-target drugs: the trend of drug research and development</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.</description><subject>Alzheimer's disease</subject><subject>Angiogenesis</subject><subject>Cancer therapies</subject><subject>Dopamine</subject><subject>Drug approval</subject><subject>Drug development</subject><subject>Drug discovery</subject><subject>Drug Discovery - economics</subject><subject>Drug Discovery - trends</subject><subject>Drugs</subject><subject>Functional foods & nutraceuticals</subject><subject>Growth factors</subject><subject>Industrial research</subject><subject>Kinases</subject><subject>Laboratories</subject><subject>Marketing - economics</subject><subject>Medicine</subject><subject>Metastasis</subject><subject>Natural products</subject><subject>Nervous system</subject><subject>Network analysis</subject><subject>Parkinson's disease</subject><subject>Pharmaceutical Preparations - economics</subject><subject>R&D</subject><subject>Research & development</subject><subject>Research - economics</subject><subject>Research - trends</subject><subject>Studies</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2012</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>DOA</sourceid><recordid>eNqNkltrFDEUxwdRbK1-A9EBQfRh19wmFx8KpXhZqBS8vYZM5szslOxkTTJFv73Z7rTsSB8kD0lOfuefnJN_UTzHaImpwO-u_BgG45ZbP8ASIYYIJw-KY6woWXCC6MOD9VHxJMYrhCoqOX9cHBEiuCScHxenX0aX-kUyoYNUNmHs4vsyraFMAYam9O1NrAwQwQS7Lk0ONnANzm83MKSnxaPWuAjPpvmk-PHxw_fzz4uLy0-r87OLheWKpIVE0gjUClVBXcmaNsCkVIwa3iBMaYuklbIyyjIurORGsLrhSuLKoLwhFT0pXu51t85HPZUeNaakQqzCSGZitScab670NvQbE_5ob3p9E_Ch0yak3jrQLSeSNi1YwmomFFcYMwrAak5Mja3NWqfTbWO9gcbmQoNxM9H5ydCvdeevNc39VUJlgTeTQPC_RohJb_powTkzgB_zuxFhSAle0Yy--ge9v7qJ6kwuoB9an--1O1F9xoTI308Fy9TyHiqPBja9zT5p-xyfJbydJWQmwe_UmTFGvfr29f_Zy59z9vUBuwbj0jp6N6beD3EOsj1og48xQHvXZIz0zua33dA7m-vJ5jntxeEH3SXd-pr-BZZz9Tg</recordid><startdate>20120629</startdate><enddate>20120629</enddate><creator>Lu, Jin-Jian</creator><creator>Pan, Wei</creator><creator>Hu, Yuan-Jia</creator><creator>Wang, Yi-Tao</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20120629</creationdate><title>Multi-target drugs: the trend of drug research and development</title><author>Lu, Jin-Jian ; Pan, Wei ; Hu, Yuan-Jia ; Wang, Yi-Tao</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c692t-808a70f795eb58b3de488943a6d0133f08c885a9c467c86a74bd69815a06a7253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2012</creationdate><topic>Alzheimer's disease</topic><topic>Angiogenesis</topic><topic>Cancer therapies</topic><topic>Dopamine</topic><topic>Drug approval</topic><topic>Drug development</topic><topic>Drug discovery</topic><topic>Drug Discovery - economics</topic><topic>Drug Discovery - trends</topic><topic>Drugs</topic><topic>Functional foods & nutraceuticals</topic><topic>Growth factors</topic><topic>Industrial research</topic><topic>Kinases</topic><topic>Laboratories</topic><topic>Marketing - economics</topic><topic>Medicine</topic><topic>Metastasis</topic><topic>Natural products</topic><topic>Nervous system</topic><topic>Network analysis</topic><topic>Parkinson's disease</topic><topic>Pharmaceutical Preparations - economics</topic><topic>R&D</topic><topic>Research & development</topic><topic>Research - economics</topic><topic>Research - trends</topic><topic>Studies</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Lu, Jin-Jian</creatorcontrib><creatorcontrib>Pan, Wei</creatorcontrib><creatorcontrib>Hu, Yuan-Jia</creatorcontrib><creatorcontrib>Wang, Yi-Tao</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological & Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science & Engineering Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies & Aerospace Collection</collection><collection>Agricultural & Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Meteorological & Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>ProQuest Biological Science Collection</collection><collection>Agricultural Science Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing & Allied Health Premium</collection><collection>Advanced Technologies & Aerospace Database</collection><collection>ProQuest Advanced Technologies & Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Lu, Jin-Jian</au><au>Pan, Wei</au><au>Hu, Yuan-Jia</au><au>Wang, Yi-Tao</au><au>Aggarwal, Bharat B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multi-target drugs: the trend of drug research and development</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2012-06-29</date><risdate>2012</risdate><volume>7</volume><issue>6</issue><spage>e40262</spage><epage>e40262</epage><pages>e40262-e40262</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Summarizing the status of drugs in the market and examining the trend of drug research and development is important in drug discovery. In this study, we compared the drug targets and the market sales of the new molecular entities approved by the U.S. Food and Drug Administration from January 2000 to December 2009. Two networks, namely, the target-target and drug-drug networks, have been set up using the network analysis tools. The multi-target drugs have much more potential, as shown by the network visualization and the market trends. We discussed the possible reasons and proposed the rational strategies for drug research and development in the future.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>22768266</pmid><doi>10.1371/journal.pone.0040262</doi><tpages>e40262</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1932-6203 |
ispartof | PloS one, 2012-06, Vol.7 (6), p.e40262-e40262 |
issn | 1932-6203 1932-6203 |
language | eng |
recordid | cdi_plos_journals_1325045108 |
source | MEDLINE; DOAJ Directory of Open Access Journals; Public Library of Science (PLoS); EZB-FREE-00999 freely available EZB journals; PubMed Central; Free Full-Text Journals in Chemistry |
subjects | Alzheimer's disease Angiogenesis Cancer therapies Dopamine Drug approval Drug development Drug discovery Drug Discovery - economics Drug Discovery - trends Drugs Functional foods & nutraceuticals Growth factors Industrial research Kinases Laboratories Marketing - economics Medicine Metastasis Natural products Nervous system Network analysis Parkinson's disease Pharmaceutical Preparations - economics R&D Research & development Research - economics Research - trends Studies |
title | Multi-target drugs: the trend of drug research and development |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T03%3A07%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multi-target%20drugs:%20the%20trend%20of%20drug%20research%20and%20development&rft.jtitle=PloS%20one&rft.au=Lu,%20Jin-Jian&rft.date=2012-06-29&rft.volume=7&rft.issue=6&rft.spage=e40262&rft.epage=e40262&rft.pages=e40262-e40262&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0040262&rft_dat=%3Cgale_plos_%3EA477004374%3C/gale_plos_%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1325045108&rft_id=info:pmid/22768266&rft_galeid=A477004374&rft_doaj_id=oai_doaj_org_article_f6283dfec24b479691143ee4b62ab1cc&rfr_iscdi=true |